New plant for Corona vaccines
Heidelberg - 11.5.2021
io-consultants supports R-Pharm in establishing an active ingredients manufacturing site for Corona vaccines and associated Fill & Finish area at its Illertissen plant.
The pharmaceutical company R-Pharm Germany GmbH in Illertissen, Southern Bavaria, is embarking on the production of vaccines against Covid-19. Their trusted partner io-consultants GmbH & Co. KG has been supporting them in all stages of the project, from manufacturing of the active ingredient to filling of the vaccine. R-Pharm is investing more than €30 million in the Illertissen site – from the laboratory and production itself to vaccine packaging and shipping.
The filling process is now being expanded following the successfully completed proof of concept, which io-consultants carried out together with R-Pharm.
With their vast experience in value chain planning, io-consultants is implementing the project and advising R-Pharm on everything from manufacturing and filling processes to active ingredients logistics.
Work is being carried out at full speed to ensure full vaccination against Covid-19 as quickly as possible. “We are delighted to have the experts of io-consultants at our side. Particularly with the time pressure in our project, their vast experience in biotech manufacturing and filling is invaluable,” says Annette Steiner-Kienzler, Project Manager at R-Pharm.
R-Pharm Germany GmbH, based in Illertissen, Germany, has many years of experience producing and packaging highly effective medicines and nutritional supplements in over 150 countries worldwide. Innovative technologies combined with a highly motivated and proficient team ensure reliability, high quality standards and excellent value for money. This means R Pharm can set the highest standards in terms of patient safety and intensive personal contact with its customers and business partners.